When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MGTA - FDA grants RMAT tag for Magenta cell therapy for inherited metabolic disorders
Magenta Therapeutics Inc.
The FDA designates Magenta Therapeutics' (MGTA+1.3%) one-time cell therapy MGTA-456 a Regenerative Medicine Advance Therapy (RMAT) for the treatment of multiple inherited metabolic disorders.
More news on: Magenta Therapeutics, Inc., Healthcare stocks news,